Iyengar Neil M, Hudis Clifford A, Gucalp Ayca
Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center; New York, NY ; Department of Medicine, Weill Cornell Medical College; New York, NY ; The Rockefeller University; New York, NY.
Curr Breast Cancer Rep. 2013 Sep 1;5(3):247-254. doi: 10.1007/s12609-013-0112-1.
The quantity and makeup of dietary fat intake are known to impact human health. Use of Omega-3 (ω-3) polyunsaturated fatty acid (PUFA) supplements has gained increasing attention for a variety of purported health benefits, including cancer prevention. Preclinical evidence has been encouraging and recent studies have expanded our understanding of the mechanisms by which ω-3 PUFAs may protect against breast cancer. However, epidemiologic studies have yielded mixed results. Recent population studies have attempted to delineate factors that may influence the effects of ω-3 PUFAs such as total fat intake and the ratio of ω-3 to ω-6 PUFA intake. Several clinical trials, including some currently ongoing, are investigating novel strategies that favorably alter endogenous fatty acid profiles in an effort to develop clinically feasible prevention methods. Identification of well-defined subpopulations that are most likely to benefit from a targeted prevention approach will likely be crucial in this effort.
众所周知,膳食脂肪摄入量的数量和构成会影响人类健康。使用欧米伽-3(ω-3)多不饱和脂肪酸(PUFA)补充剂因各种所谓的健康益处,包括预防癌症,而越来越受到关注。临床前证据令人鼓舞,最近的研究扩展了我们对ω-3多不饱和脂肪酸预防乳腺癌机制的理解。然而,流行病学研究结果不一。最近的人群研究试图确定可能影响ω-3多不饱和脂肪酸效果的因素,如总脂肪摄入量以及ω-3与ω-6多不饱和脂肪酸摄入量的比例。包括一些正在进行的试验在内的多项临床试验正在研究能有利地改变内源性脂肪酸谱的新策略,以努力开发临床上可行的预防方法。确定最有可能从针对性预防方法中获益的明确亚人群在这项工作中可能至关重要。